Skip to content

Renal Perfusion, Filtration and Oxygenation During Cardiopulmonary Bypass (CPB)

Renal Perfusion, Filtration and Oxygenation During Cardiopulmonary Bypass (CPB)

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02405195
Acronym
ECCSTUD
Enrollment
28
Registered
2015-04-01
Start date
2011-10-31
Completion date
2016-01-31
Last updated
2019-05-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Complication of Extracorporeal Circulation, Renal Impairment

Brief summary

Acute kidney injury is a common complication after cardiac surgery with cardiopulmonary bypass (CPB). This study aims to investigate the effects of CPB on renal perfusion, filtration and oxygenation.

Detailed description

After approval of the regional ethics committee, patients (n=16) undergoing combined cardiac surgery procedures during normothermic CPB will be included after informed consent. Systemic and renal variables will be measured by pulmonary artery and renal vein catheters. Glomerular filtration rate (GFR) will be measured by renal extraction of 51Cr-EDTA and renal blood flow (RBF) by the infusion clearance technique for para-aminohippuric acid (PAH) corrected for by renal extraction of PAH. Repeated measures ANOVA followed by Fisher's PLSD post-hoc test were used for statistical analyses

Interventions

PROCEDUREcardiopulmonary bypass

During cardiac surgery, the subjects are routinely undergoing cardiopulmonary bypass

Sponsors

Sahlgrenska University Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
19 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Preserved left ventricular function (LVEF \> 50%) * Normal preoperative S-creatinine

Exclusion criteria

* Contraindications to radiocontrast * Cardiac transplantation och dissection

Design outcomes

Primary

MeasureTime frameDescription
Renal Blood Flow (RBF)6 hoursRenal blood flow measured with PAH clearance
Glomerular Filtration Rate (GFR)6 hoursGFR measured by renal extraction of 51Cr-EDTA
Renal Oxygenation6 hoursRenal oxygen extraction, defined as renal oxygen consumption divided by renal oxygen delivery

Secondary

MeasureTime frameDescription
Excretion of NAG24 hoursUrinary biomarker of tubular renal injury
Development of Acute Kidney Injury (AKI)72 hoursAKI according to AKIN criteria

Countries

Sweden

Participant flow

Participants by arm

ArmCount
CardioPulmonary Bypass
Open cardiac surgery with normothermic Cardiopulmonary Bypass at 2.5 L/min/m2.
18
Total18

Baseline characteristics

CharacteristicCardioPulmonary Bypass
Age, Categorical
<=18 years
0 Participants
Age, Categorical
>=65 years
13 Participants
Age, Categorical
Between 18 and 65 years
5 Participants
Left ventricular ejection fraction58 %
STANDARD_DEVIATION 5
Race and Ethnicity Not Collected— Participants
Region of Enrollment
Sweden
18 participants
Serum creatinine87 micromol per litre
STANDARD_DEVIATION 11
Sex: Female, Male
Female
2 Participants
Sex: Female, Male
Male
16 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 18
other
Total, other adverse events
4 / 18
serious
Total, serious adverse events
0 / 18

Outcome results

Primary

Glomerular Filtration Rate (GFR)

GFR measured by renal extraction of 51Cr-EDTA

Time frame: 6 hours

ArmMeasureGroupValue (MEAN)Dispersion
CardioPulmonaryBypassGlomerular Filtration Rate (GFR)Before CPB67 ml per minute per 1.73 m2 body surfaceStandard Deviation 23
CardioPulmonaryBypassGlomerular Filtration Rate (GFR)CPB 30 minutes68 ml per minute per 1.73 m2 body surfaceStandard Deviation 23
CardioPulmonaryBypassGlomerular Filtration Rate (GFR)CPB 60 minutes70 ml per minute per 1.73 m2 body surfaceStandard Deviation 19
CardioPulmonaryBypassGlomerular Filtration Rate (GFR)Post CPB (30 - 60 minutes)67 ml per minute per 1.73 m2 body surfaceStandard Deviation 18
Comparison: Repeated measures ANOVAp-value: 0.972ANOVA
Primary

Renal Blood Flow (RBF)

Renal blood flow measured with PAH clearance

Time frame: 6 hours

ArmMeasureGroupValue (MEAN)Dispersion
CardioPulmonaryBypassRenal Blood Flow (RBF)Pre CPB554 ml per minute per 1.73 m2 body surfaceStandard Deviation 126
CardioPulmonaryBypassRenal Blood Flow (RBF)CPB 30 minutes524 ml per minute per 1.73 m2 body surfaceStandard Deviation 116
CardioPulmonaryBypassRenal Blood Flow (RBF)CPB 60 minutes564 ml per minute per 1.73 m2 body surfaceStandard Deviation 162
CardioPulmonaryBypassRenal Blood Flow (RBF)Post CPB (30 - 60 minutes)558 ml per minute per 1.73 m2 body surfaceStandard Deviation 130
Comparison: Repeated measures ANOVA throughout measurement period (before, during and after CPB).p-value: 0.638ANOVA
Primary

Renal Oxygenation

Renal oxygen extraction, defined as renal oxygen consumption divided by renal oxygen delivery

Time frame: 6 hours

ArmMeasureGroupValue (MEAN)Dispersion
CardioPulmonaryBypassRenal OxygenationPre CPB0.09 fractionStandard Deviation 0.03
CardioPulmonaryBypassRenal OxygenationCPB 30 minutes0.12 fractionStandard Deviation 0.05
CardioPulmonaryBypassRenal OxygenationCPB 60 minutes0.13 fractionStandard Deviation 0.06
CardioPulmonaryBypassRenal OxygenationPost CPB (30 - 60 minutes)0.16 fractionStandard Deviation 0.05
Comparison: Repeated measures ANOVAp-value: <0.001ANOVA
Secondary

Development of Acute Kidney Injury (AKI)

AKI according to AKIN criteria

Time frame: 72 hours

Secondary

Excretion of NAG

Urinary biomarker of tubular renal injury

Time frame: 24 hours

Source: ClinicalTrials.gov · Data processed: Feb 28, 2026